Coralie Courtinard
Université de Bordeaux(FR)Bordeaux Population Health(FR)UniCancer Group(FR)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Economic and Financial Impacts of Cancer
Most-Cited Works
- → Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort(2018)277 cited
- → Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016(2020)186 cited
- → Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort(2021)127 cited
- → Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort(2021)85 cited
- → Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study(2016)72 cited
- → Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients(2018)65 cited
- → Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort(2019)54 cited
- → Impact of body mass index on overall survival in patients with metastatic breast cancer(2020)48 cited
- → Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database(2021)46 cited
- → Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis(2020)37 cited